Current Report · Items 7.01, 9.01 · 8-K
QHSLab, Inc.
Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure. On August 3, 2026, QHSLab, Inc. (the “Company”) issued a press release titled “QHSLab (OTCQB:USAQ) Reports Second Quarter and First Half 2026 Unaudited Financial Results” A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.…
Filed Aug 3, 2026Accepted Aug 3, 2026, 8:30 AM EDTCIK 856984Accession 0001493152-26-035749
Company context
QHSLab, Inc. (OTCQB: USAQ) is a digital health technology leader providing preventive screening, assessment, and workflow solutions for primary care providers. Its tools help practices identify, document, and manage underdiagnosed chronic and behavioral conditions efficiently and profitably. Learn more at www.qhslab.com
Current securities
Historical securities (1)
Registered securities in this filing
QHSLab, Inc. · 8-K · Filed 2026-08-03
As filed in this accession. Current/historical status below comes from the governed listing record; the cover itself remains exact to this filing.
Common Stock, $0.0001 par value
- Exchange
- OTC
- Classification
- COMMON
- Status
- Current
Filing context
Context: AsOf2026-08-03
Dimensions: Not supplied
Accession 000149315226035749 · 1 registered-security cover member
Read the exact SEC filing ↗Disclosure sections
Items 7.01, 9.01Select an item to read the extracted section. The as-filed document remains the primary evidence.
Item 7.01Item 7.01 - Regulation FD Disclosure
Item
7.01 Regulation FD Disclosure.
On
August 3, 2026, QHSLab, Inc. (the “Company”) issued a press release titled “QHSLab (OTCQB:USAQ) Reports Second Quarter
and First Half 2026 Unaudited Financial Results” A copy of the press release is furnished as Exhibit 99.1 to this Current Report
on Form 8-K and is incorporated herein by reference.
The
information in the press release annexed as Exhibit 99.1 is furnished pursuant to Item 7.01 and shall not be deemed to be “filed”
for the purpose of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject
to the liabilities of that section, nor shall it be deemed incorporated by reference into any filing by the Company under the Exchange
Act or the Securities Act of 1933, as amended, regardless of any general incorporation language in such filing, unless expressly incorporated
by specific reference in such filing. This Current Report on Form 8-K will not be deemed an admission as to the materiality of any information
in the Report that is required to be disclosed solely by Regulation FD.
We
do not have, and expressly disclaim, any obligation to release publicly any updates or any changes in our expectations or any change
in events, conditions, or circumstances on which any forward-looking statement is based.
We
use, and will continue to use, our website (https://usaqcorp.com), press releases, and various social media channels, including our Twitter
account ( https://twitter.com/qhslabinc ), LinkedIn account ( https://www.linkedin.com/company/65407282/ ), Facebook account
( https://www.facebook.com/QHSLabs) and Instagram account ( https://www.instagram.com/qhslabs/) as additional means of disclosing
public information to investors, the media and others interested in the Company. It is possible that certain information we post on our
website, disseminate in press releases and on social media could be deemed to be material information, and we encourage investors, the
media and others interested in the Company to review the business and financial information that we post on our website, disseminate
in press releases and on the social media channels identified above, as such information could be deemed to be material information.
Filed exhibits (1)
EX-99.1 (by filename) ex99-1.htmEX-99.1
2
ex99-1.htm
EX-99.1
Exhibit
99.1
QHSLab
(OTCQB:USAQ) Reports Second Quarter and First Half 2026 Unaudited Financial Results
Integrated
Service Program (ISP) Revenue More Than Doubles Year-over-Year as Gross Margins Expand and Financing Costs Decline
West
Palm Beach, FL, August 3, 2026 (GLOBE NEWSWIRE) - QHSLab, Inc. (the “Company”) (OTCQB: USAQ), a healthcare technology
and software-as-a-service (SaaS) company focused on enabling primary care providers to improve patient outcomes while increasing practice
revenue through reimbursable preventive care, digital health and clinical decision support solutions, today reported its unaudited financial
results for the three and six months ended June 30, 2026.
Management
believes the second quarter reflects continued momentum in the Company’s strategic transition toward recurring revenue, software-enabled
healthcare platform, led by strong growth in its Integrated Service Program (“ISP”), expanding gross margins and significantly
reduced financing costs.
Second
Quarter 2026 Financial Highlights
For
the three months ended June 30, 2026:
ISP
revenue increased 86.4% to $491,399, compared with $263,628 during the second q…
Open exhibit ↗